 | • レポートコード：MRC2-11QY01518 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は高血圧治療薬のグローバル市場について調査・分析したレポートです。種類別（カルシウム拮抗薬、利尿薬、ベータ遮断薬、血管拡張薬、アンジオテンシン変換酵素阻害薬、アルファ遮断薬、アンジオテンシン受容体遮断薬、レニン阻害薬）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別高血圧治療薬の競争状況、市場シェア ・世界の高血圧治療薬市場：種類別市場規模 2015年-2020年（カルシウム拮抗薬、利尿薬、ベータ遮断薬、血管拡張薬、アンジオテンシン変換酵素阻害薬、アルファ遮断薬、アンジオテンシン受容体遮断薬、レニン阻害薬） ・世界の高血圧治療薬市場：種類別市場規模予測 2021年-2026年（カルシウム拮抗薬、利尿薬、ベータ遮断薬、血管拡張薬、アンジオテンシン変換酵素阻害薬、アルファ遮断薬、アンジオテンシン受容体遮断薬、レニン阻害薬） ・世界の高血圧治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の高血圧治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の高血圧治療薬市場分析：米国、カナダ ・ヨーロッパの高血圧治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの高血圧治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の高血圧治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの高血圧治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Daiichi Sankyo、Actelion Pharmaceuticals、Boehringer Ingelheim、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The standard definition of high blood pressure is determined by the Joint National Committee (JNC) on Detection, Evaluation, and Diagnosis of High Blood Pressure. A person is considered to have high blood pressure after three to six elevated blood pressure measurements over several months. These definitions apply to adults who are healthy and not using medication for high blood pressure. If the two pressures fall in different categories, the higher one is used to determine the severity of hypertension.
With an increase in the population of older people, the market for hypertension drugs has a positive outlook over the forecast period. The prevalence of hypertension is high among the older population with close to 70% of the patients with high BP above the age of 60. Currently, close to 11% of the global population is aged 60 years or over and is estimated to reach nearly 22% by 2050. Since the risk of developing pulmonary hypertension increases with age, a growing older population will aid in the growth prospects of the hypertension drugs market in the coming years.
Market Analysis and Insights: Global Hypertension Drugs Market
The global Hypertension Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hypertension Drugs Scope and Market Size
Hypertension Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hypertension Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hypertension Drugs market is segmented into
Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors
Segment by Application, the Hypertension Drugs market is segmented into
Hospitals
Clinics
Others
Regional and Country-level Analysis
The Hypertension Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hypertension Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hypertension Drugs Market Share Analysis
Hypertension Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hypertension Drugs business, the date to enter into the Hypertension Drugs market, Hypertension Drugs product introduction, recent developments, etc.
The major vendors covered:
Novartis
Daiichi Sankyo
Actelion Pharmaceuticals
Boehringer Ingelheim
Pfizer
…
1 Study Coverage
1.1 Hypertension Drugs Product Introduction
1.2 Market Segments
1.3 Key Hypertension Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hypertension Drugs Market Size Growth Rate by Type
1.4.2 Calcium Channel Blockers
1.4.3 Diuretics
1.4.4 Beta Blockers Vasodilators
1.4.5 Angiotensin Converting Enzyme Inhibitors
1.4.6 Alpha Blockers
1.4.7 Angiotensin Receptor Blockers
1.4.8 Renin Inhibitors
1.5 Market by Application
1.5.1 Global Hypertension Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hypertension Drugs Market Size, Estimates and Forecasts
2.1.1 Global Hypertension Drugs Revenue 2015-2026
2.1.2 Global Hypertension Drugs Sales 2015-2026
2.2 Global Hypertension Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hypertension Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hypertension Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hypertension Drugs Competitor Landscape by Players
3.1 Hypertension Drugs Sales by Manufacturers
3.1.1 Hypertension Drugs Sales by Manufacturers (2015-2020)
3.1.2 Hypertension Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Hypertension Drugs Revenue by Manufacturers
3.2.1 Hypertension Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Hypertension Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hypertension Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hypertension Drugs Revenue in 2019
3.2.5 Global Hypertension Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hypertension Drugs Price by Manufacturers
3.4 Hypertension Drugs Manufacturing Base Distribution, Product Types
3.4.1 Hypertension Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hypertension Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Hypertension Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hypertension Drugs Market Size by Type (2015-2020)
4.1.1 Global Hypertension Drugs Sales by Type (2015-2020)
4.1.2 Global Hypertension Drugs Revenue by Type (2015-2020)
4.1.3 Hypertension Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hypertension Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Hypertension Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Hypertension Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Hypertension Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hypertension Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hypertension Drugs Market Size by Application (2015-2020)
5.1.1 Global Hypertension Drugs Sales by Application (2015-2020)
5.1.2 Global Hypertension Drugs Revenue by Application (2015-2020)
5.1.3 Hypertension Drugs Price by Application (2015-2020)
5.2 Hypertension Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Hypertension Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Hypertension Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Hypertension Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hypertension Drugs by Country
6.1.1 North America Hypertension Drugs Sales by Country
6.1.2 North America Hypertension Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hypertension Drugs Market Facts & Figures by Type
6.3 North America Hypertension Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Hypertension Drugs by Country
7.1.1 Europe Hypertension Drugs Sales by Country
7.1.2 Europe Hypertension Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hypertension Drugs Market Facts & Figures by Type
7.3 Europe Hypertension Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hypertension Drugs by Region
8.1.1 Asia Pacific Hypertension Drugs Sales by Region
8.1.2 Asia Pacific Hypertension Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hypertension Drugs Market Facts & Figures by Type
8.3 Asia Pacific Hypertension Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hypertension Drugs by Country
9.1.1 Latin America Hypertension Drugs Sales by Country
9.1.2 Latin America Hypertension Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hypertension Drugs Market Facts & Figures by Type
9.3 Central & South America Hypertension Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hypertension Drugs by Country
10.1.1 Middle East and Africa Hypertension Drugs Sales by Country
10.1.2 Middle East and Africa Hypertension Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hypertension Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Hypertension Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Hypertension Drugs Products Offered
11.1.5 Novartis Related Developments
11.2 Daiichi Sankyo
11.2.1 Daiichi Sankyo Corporation Information
11.2.2 Daiichi Sankyo Description and Business Overview
11.2.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Daiichi Sankyo Hypertension Drugs Products Offered
11.2.5 Daiichi Sankyo Related Developments
11.3 Actelion Pharmaceuticals
11.3.1 Actelion Pharmaceuticals Corporation Information
11.3.2 Actelion Pharmaceuticals Description and Business Overview
11.3.3 Actelion Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Actelion Pharmaceuticals Hypertension Drugs Products Offered
11.3.5 Actelion Pharmaceuticals Related Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Description and Business Overview
11.4.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Boehringer Ingelheim Hypertension Drugs Products Offered
11.4.5 Boehringer Ingelheim Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Hypertension Drugs Products Offered
11.5.5 Pfizer Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Hypertension Drugs Products Offered
11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hypertension Drugs Market Estimates and Projections by Region
12.1.1 Global Hypertension Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Hypertension Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Hypertension Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Hypertension Drugs Sales Forecast (2021-2026)
12.2.2 North America: Hypertension Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Hypertension Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Hypertension Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Hypertension Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Hypertension Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Hypertension Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hypertension Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hypertension Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hypertension Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hypertension Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Hypertension Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Hypertension Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Hypertension Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Hypertension Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hypertension Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hypertension Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hypertension Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hypertension Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hypertension Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hypertension Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Hypertension Drugs Market Segments
Table 2. Ranking of Global Top Hypertension Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hypertension Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Calcium Channel Blockers
Table 5. Major Manufacturers of Diuretics
Table 6. Major Manufacturers of Beta Blockers Vasodilators
Table 7. Major Manufacturers of Angiotensin Converting Enzyme Inhibitors
Table 8. Major Manufacturers of Alpha Blockers
Table 9. Major Manufacturers of Angiotensin Receptor Blockers
Table 10. Major Manufacturers of Renin Inhibitors
Table 11. Global Hypertension Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Hypertension Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Hypertension Drugs Sales by Regions 2015-2020 (K MT)
Table 14. Global Hypertension Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global Hypertension Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Hypertension Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Hypertension Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Hypertension Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Hypertension Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypertension Drugs as of 2019)
Table 20. Hypertension Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Hypertension Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Hypertension Drugs Price (2015-2020) (USD/MT)
Table 23. Hypertension Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Hypertension Drugs Product Type
Table 25. Date of International Manufacturers Enter into Hypertension Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Hypertension Drugs Sales by Type (2015-2020) (K MT)
Table 28. Global Hypertension Drugs Sales Share by Type (2015-2020)
Table 29. Global Hypertension Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Hypertension Drugs Revenue Share by Type (2015-2020)
Table 31. Hypertension Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Hypertension Drugs Sales by Application (2015-2020) (K MT)
Table 33. Global Hypertension Drugs Sales Share by Application (2015-2020)
Table 34. North America Hypertension Drugs Sales by Country (2015-2020) (K MT)
Table 35. North America Hypertension Drugs Sales Market Share by Country (2015-2020)
Table 36. North America Hypertension Drugs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Hypertension Drugs Revenue Market Share by Country (2015-2020)
Table 38. North America Hypertension Drugs Sales by Type (2015-2020) (K MT)
Table 39. North America Hypertension Drugs Sales Market Share by Type (2015-2020)
Table 40. North America Hypertension Drugs Sales by Application (2015-2020) (K MT)
Table 41. North America Hypertension Drugs Sales Market Share by Application (2015-2020)
Table 42. Europe Hypertension Drugs Sales by Country (2015-2020) (K MT)
Table 43. Europe Hypertension Drugs Sales Market Share by Country (2015-2020)
Table 44. Europe Hypertension Drugs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Hypertension Drugs Revenue Market Share by Country (2015-2020)
Table 46. Europe Hypertension Drugs Sales by Type (2015-2020) (K MT)
Table 47. Europe Hypertension Drugs Sales Market Share by Type (2015-2020)
Table 48. Europe Hypertension Drugs Sales by Application (2015-2020) (K MT)
Table 49. Europe Hypertension Drugs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Hypertension Drugs Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Hypertension Drugs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Hypertension Drugs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Hypertension Drugs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Hypertension Drugs Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Hypertension Drugs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Hypertension Drugs Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Hypertension Drugs Sales Market Share by Application (2015-2020)
Table 58. Latin America Hypertension Drugs Sales by Country (2015-2020) (K MT)
Table 59. Latin America Hypertension Drugs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Hypertension Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Hypertension Drugs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Hypertension Drugs Sales by Type (2015-2020) (K MT)
Table 63. Latin America Hypertension Drugs Sales Market Share by Type (2015-2020)
Table 64. Latin America Hypertension Drugs Sales by Application (2015-2020) (K MT)
Table 65. Latin America Hypertension Drugs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Hypertension Drugs Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Hypertension Drugs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Hypertension Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Hypertension Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Hypertension Drugs Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Hypertension Drugs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Hypertension Drugs Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Hypertension Drugs Sales Market Share by Application (2015-2020)
Table 74. Novartis Corporation Information
Table 75. Novartis Description and Major Businesses
Table 76. Novartis Hypertension Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Novartis Product
Table 78. Novartis Recent Development
Table 79. Daiichi Sankyo Corporation Information
Table 80. Daiichi Sankyo Description and Major Businesses
Table 81. Daiichi Sankyo Hypertension Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Daiichi Sankyo Product
Table 83. Daiichi Sankyo Recent Development
Table 84. Actelion Pharmaceuticals Corporation Information
Table 85. Actelion Pharmaceuticals Description and Major Businesses
Table 86. Actelion Pharmaceuticals Hypertension Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Actelion Pharmaceuticals Product
Table 88. Actelion Pharmaceuticals Recent Development
Table 89. Boehringer Ingelheim Corporation Information
Table 90. Boehringer Ingelheim Description and Major Businesses
Table 91. Boehringer Ingelheim Hypertension Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Boehringer Ingelheim Product
Table 93. Boehringer Ingelheim Recent Development
Table 94. Pfizer Corporation Information
Table 95. Pfizer Description and Major Businesses
Table 96. Pfizer Hypertension Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Pfizer Product
Table 98. Pfizer Recent Development
Table 99. Global Hypertension Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 100. Global Hypertension Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Hypertension Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Hypertension Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Hypertension Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 104. North America: Hypertension Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Hypertension Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 106. Europe: Hypertension Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Hypertension Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 108. Asia Pacific: Hypertension Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Hypertension Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 110. Latin America: Hypertension Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Hypertension Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 112. Middle East and Africa: Hypertension Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Hypertension Drugs Players
Table 117. Hypertension Drugs Customers List
Table 118. Hypertension Drugs Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Hypertension Drugs Product Picture
Figure 2. Global Hypertension Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Calcium Channel Blockers Product Picture
Figure 4. Diuretics Product Picture
Figure 5. Beta Blockers Vasodilators Product Picture
Figure 6. Angiotensin Converting Enzyme Inhibitors Product Picture
Figure 7. Alpha Blockers Product Picture
Figure 8. Angiotensin Receptor Blockers Product Picture
Figure 9. Renin Inhibitors Product Picture
Figure 10. Global Hypertension Drugs Sales Market Share by Application in 2020 & 2026
Figure 11. Hospitals
Figure 12. Clinics
Figure 13. Others
Figure 14. Hypertension Drugs Report Years Considered
Figure 15. Global Hypertension Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global Hypertension Drugs Sales 2015-2026 (K MT)
Figure 17. Global Hypertension Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Hypertension Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Hypertension Drugs Sales Market Share by Region in 2019
Figure 20. Global Hypertension Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Hypertension Drugs Revenue Market Share by Region in 2019
Figure 22. Global Hypertension Drugs Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Hypertension Drugs Revenue in 2019
Figure 24. Hypertension Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Hypertension Drugs Sales Market Share by Type (2015-2020)
Figure 26. Global Hypertension Drugs Sales Market Share by Type in 2019
Figure 27. Global Hypertension Drugs Revenue Market Share by Type (2015-2020)
Figure 28. Global Hypertension Drugs Revenue Market Share by Type in 2019
Figure 29. Global Hypertension Drugs Market Share by Price Range (2015-2020)
Figure 30. Global Hypertension Drugs Sales Market Share by Application (2015-2020)
Figure 31. Global Hypertension Drugs Sales Market Share by Application in 2019
Figure 32. Global Hypertension Drugs Revenue Market Share by Application (2015-2020)
Figure 33. Global Hypertension Drugs Revenue Market Share by Application in 2019
Figure 34. North America Hypertension Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 35. North America Hypertension Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Hypertension Drugs Sales Market Share by Country in 2019
Figure 37. North America Hypertension Drugs Revenue Market Share by Country in 2019
Figure 38. U.S. Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 39. U.S. Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 41. Canada Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Hypertension Drugs Market Share by Type in 2019
Figure 43. North America Hypertension Drugs Market Share by Application in 2019
Figure 44. Europe Hypertension Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 45. Europe Hypertension Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Hypertension Drugs Sales Market Share by Country in 2019
Figure 47. Europe Hypertension Drugs Revenue Market Share by Country in 2019
Figure 48. Germany Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. Germany Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. France Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. U.K. Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. Italy Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 57. Russia Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Hypertension Drugs Market Share by Type in 2019
Figure 59. Europe Hypertension Drugs Market Share by Application in 2019
Figure 60. Asia Pacific Hypertension Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 61. Asia Pacific Hypertension Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Hypertension Drugs Sales Market Share by Region in 2019
Figure 63. Asia Pacific Hypertension Drugs Revenue Market Share by Region in 2019
Figure 64. China Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. China Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. Japan Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. South Korea Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. India Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Australia Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Taiwan Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Indonesia Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Thailand Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Malaysia Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Philippines Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 85. Vietnam Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Hypertension Drugs Market Share by Type in 2019
Figure 87. Asia Pacific Hypertension Drugs Market Share by Application in 2019
Figure 88. Latin America Hypertension Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 89. Latin America Hypertension Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Hypertension Drugs Sales Market Share by Country in 2019
Figure 91. Latin America Hypertension Drugs Revenue Market Share by Country in 2019
Figure 92. Mexico Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Mexico Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 95. Brazil Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 97. Argentina Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Hypertension Drugs Market Share by Type in 2019
Figure 99. Latin America Hypertension Drugs Market Share by Application in 2019
Figure 100. Middle East and Africa Hypertension Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 101. Middle East and Africa Hypertension Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Hypertension Drugs Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Hypertension Drugs Revenue Market Share by Country in 2019
Figure 104. Turkey Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 105. Turkey Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 107. Saudi Arabia Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Hypertension Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 109. U.A.E Hypertension Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Hypertension Drugs Market Share by Type in 2019
Figure 111. Middle East and Africa Hypertension Drugs Market Share by Application in 2019
Figure 112. North America Hypertension Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. North America Hypertension Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Hypertension Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Europe Hypertension Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Hypertension Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Asia Pacific Hypertension Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Hypertension Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Latin America Hypertension Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Hypertension Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Middle East and Africa Hypertension Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
抗高血圧薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-Hypertensive Drugs Market The global Anti-Hypertensive Drugs market size is projected to reach US$ 40970 million by 2026, from US$ 40270 million in 2020, at a CAGR of 1.6%% during 2021-2026. Global Anti-Hypertensive Drugs Scope and Market Size Anti-Hypertens…- バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…
- 肺動脈性肺高血圧症（PAH）の世界市場（～2026年） Market Analysis and Insights: Global Pulmonary Arterial Hypertension (PAH) Market The global Pulmonary Arterial Hypertension (PAH) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pulmonary Arterial Hypertension (PAH) S…
- 心血管薬の世界市場（～2026年） Cardiovascular Drugs and Therapy is a bimonthly peer-reviewed medical journal covering pharmacotherapy as it relates to cardiology. It was established in 1987 and is published by Springer Science+Business Media on behalf of the International Society of Cardiovascular Pharmacotherapy, of which it is …
- 特発性頭蓋内圧亢進症治療薬の世界市場（～2026年） A drug used to treat idiopathic intracranial hypertension. Market Analysis and Insights: Global Idiopathic Intracranial Hypertension Therapeutics Market The global Idiopathic Intracranial Hypertension Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020,…